Structured around development of what could be the next-generation of drug delivery platform anchored in use of unique porous-wall glass microspheres that - combine with biocompatible and bioactive matrices - are capable of protecting, delivering, and releasing API as solid, liquid, even gas, SpheroFill is developing a different kind of drug delivery platform that would allow for protected, controlled release of drugs over time. Management suggest that their very different approach could improve compliance by reducing dose frequency while also enabling oral formulations that are not possible with present technology.
